Curcumin in Osteosarcoma Therapy: Combining With Immunotherapy, Chemotherapeutics, Bone Tissue Engineering Materials and Potential Synergism With Photodynamic Therapy

Osteosarcoma is a dominating malignant bone tumor with high mortality due to pulmonary metastases. Furthermore, because of the cancer cell erosion and surgery resection, osteosarcoma always causes bone defects, which means dysfunction and disfigurement are seldom inevitable. Although various advance...

Full description

Bibliographic Details
Main Authors: Chunfeng Xu, Mingjie Wang, Wei Guo, Wei Sun, Yuelian Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-05-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.672490/full
_version_ 1818606593444413440
author Chunfeng Xu
Mingjie Wang
Wei Guo
Wei Sun
Wei Sun
Yuelian Liu
author_facet Chunfeng Xu
Mingjie Wang
Wei Guo
Wei Sun
Wei Sun
Yuelian Liu
author_sort Chunfeng Xu
collection DOAJ
description Osteosarcoma is a dominating malignant bone tumor with high mortality due to pulmonary metastases. Furthermore, because of the cancer cell erosion and surgery resection, osteosarcoma always causes bone defects, which means dysfunction and disfigurement are seldom inevitable. Although various advanced treatments (e.g. chemotherapy, immunotherapy, radiotherapy) are coming up, the 5-year survival rate for osteosarcoma with metastases is still dismal. In line with this, the more potent treatments for osteosarcoma are in high demand. Curcumin, a perennial herb, has been reportedly applied in the therapy of various types of tumors via different mechanisms. In vitro, it has also been reported that curcumin can inhibit the proliferation of osteosarcoma cell lines and can be used to repair bone defects. This seems curcumin is a promising candidate in osteosarcoma treatment. However, due to its congenital property like hydrophobicity, and low bioavailability, affecting its anticancer effect, clinical applications of curcumin are highly limited. To enhance its performance in cancer therapies, some synergist approaches with curcumin have emerged. The present review presents some prospective ones (i.e. combinations with immunotherapy, chemotherapeutics, bone tissue engineering, and biomaterials) applied in osteosarcoma treatment. Additionally, with the advancements of photodynamic therapy in cancer therapy, this review also prospects the combination of curcumin with photodynamic therapy in osteosarcoma treatment.
first_indexed 2024-12-16T14:13:19Z
format Article
id doaj.art-691ecbec320949d880c07593a652c8e6
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-12-16T14:13:19Z
publishDate 2021-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-691ecbec320949d880c07593a652c8e62022-12-21T22:28:42ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2021-05-011110.3389/fonc.2021.672490672490Curcumin in Osteosarcoma Therapy: Combining With Immunotherapy, Chemotherapeutics, Bone Tissue Engineering Materials and Potential Synergism With Photodynamic TherapyChunfeng Xu0Mingjie Wang1Wei Guo2Wei Sun3Wei Sun4Yuelian Liu5Section of Restorative and Reconstructive Oral Care, Department of Oral Health Sciences, Academic Center for Dentistry Amsterdam (ACTA), University of Amsterdam and Vrije Universiteit Amsterdam, Amsterdam, NetherlandsSection of Restorative and Reconstructive Oral Care, Department of Oral Health Sciences, Academic Center for Dentistry Amsterdam (ACTA), University of Amsterdam and Vrije Universiteit Amsterdam, Amsterdam, NetherlandsDepartment of Oral–Maxillofacial and Head–Neck Oncology, Shanghai Ninth People’s Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, ChinaDepartment of Mechanical Engineering, Drexel University, Philadelphia, PA, United StatesDepartment of Mechanical Engineering, Tsinghua University, Beijing, ChinaSection of Restorative and Reconstructive Oral Care, Department of Oral Health Sciences, Academic Center for Dentistry Amsterdam (ACTA), University of Amsterdam and Vrije Universiteit Amsterdam, Amsterdam, NetherlandsOsteosarcoma is a dominating malignant bone tumor with high mortality due to pulmonary metastases. Furthermore, because of the cancer cell erosion and surgery resection, osteosarcoma always causes bone defects, which means dysfunction and disfigurement are seldom inevitable. Although various advanced treatments (e.g. chemotherapy, immunotherapy, radiotherapy) are coming up, the 5-year survival rate for osteosarcoma with metastases is still dismal. In line with this, the more potent treatments for osteosarcoma are in high demand. Curcumin, a perennial herb, has been reportedly applied in the therapy of various types of tumors via different mechanisms. In vitro, it has also been reported that curcumin can inhibit the proliferation of osteosarcoma cell lines and can be used to repair bone defects. This seems curcumin is a promising candidate in osteosarcoma treatment. However, due to its congenital property like hydrophobicity, and low bioavailability, affecting its anticancer effect, clinical applications of curcumin are highly limited. To enhance its performance in cancer therapies, some synergist approaches with curcumin have emerged. The present review presents some prospective ones (i.e. combinations with immunotherapy, chemotherapeutics, bone tissue engineering, and biomaterials) applied in osteosarcoma treatment. Additionally, with the advancements of photodynamic therapy in cancer therapy, this review also prospects the combination of curcumin with photodynamic therapy in osteosarcoma treatment.https://www.frontiersin.org/articles/10.3389/fonc.2021.672490/fullosteosarcomacurcuminimmunotherapychemotherapybone tissue engineeringbiomaterials
spellingShingle Chunfeng Xu
Mingjie Wang
Wei Guo
Wei Sun
Wei Sun
Yuelian Liu
Curcumin in Osteosarcoma Therapy: Combining With Immunotherapy, Chemotherapeutics, Bone Tissue Engineering Materials and Potential Synergism With Photodynamic Therapy
Frontiers in Oncology
osteosarcoma
curcumin
immunotherapy
chemotherapy
bone tissue engineering
biomaterials
title Curcumin in Osteosarcoma Therapy: Combining With Immunotherapy, Chemotherapeutics, Bone Tissue Engineering Materials and Potential Synergism With Photodynamic Therapy
title_full Curcumin in Osteosarcoma Therapy: Combining With Immunotherapy, Chemotherapeutics, Bone Tissue Engineering Materials and Potential Synergism With Photodynamic Therapy
title_fullStr Curcumin in Osteosarcoma Therapy: Combining With Immunotherapy, Chemotherapeutics, Bone Tissue Engineering Materials and Potential Synergism With Photodynamic Therapy
title_full_unstemmed Curcumin in Osteosarcoma Therapy: Combining With Immunotherapy, Chemotherapeutics, Bone Tissue Engineering Materials and Potential Synergism With Photodynamic Therapy
title_short Curcumin in Osteosarcoma Therapy: Combining With Immunotherapy, Chemotherapeutics, Bone Tissue Engineering Materials and Potential Synergism With Photodynamic Therapy
title_sort curcumin in osteosarcoma therapy combining with immunotherapy chemotherapeutics bone tissue engineering materials and potential synergism with photodynamic therapy
topic osteosarcoma
curcumin
immunotherapy
chemotherapy
bone tissue engineering
biomaterials
url https://www.frontiersin.org/articles/10.3389/fonc.2021.672490/full
work_keys_str_mv AT chunfengxu curcumininosteosarcomatherapycombiningwithimmunotherapychemotherapeuticsbonetissueengineeringmaterialsandpotentialsynergismwithphotodynamictherapy
AT mingjiewang curcumininosteosarcomatherapycombiningwithimmunotherapychemotherapeuticsbonetissueengineeringmaterialsandpotentialsynergismwithphotodynamictherapy
AT weiguo curcumininosteosarcomatherapycombiningwithimmunotherapychemotherapeuticsbonetissueengineeringmaterialsandpotentialsynergismwithphotodynamictherapy
AT weisun curcumininosteosarcomatherapycombiningwithimmunotherapychemotherapeuticsbonetissueengineeringmaterialsandpotentialsynergismwithphotodynamictherapy
AT weisun curcumininosteosarcomatherapycombiningwithimmunotherapychemotherapeuticsbonetissueengineeringmaterialsandpotentialsynergismwithphotodynamictherapy
AT yuelianliu curcumininosteosarcomatherapycombiningwithimmunotherapychemotherapeuticsbonetissueengineeringmaterialsandpotentialsynergismwithphotodynamictherapy